Organization
Michio Hirano, MD
1 clinical trial
Clinical trial
A Multiple Ascending Phase 1 Dose Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione LevelsStatus: Recruiting, Estimated PCD: 2024-06-01